MarketPulse

Chief Financial Officer

5 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Inventiva Bolsters Leadership Ranks Ahead of Pivotal Lanifibranor Phase 3 Data

Inventiva appoints three senior executives to strengthen leadership before Phase 3 lanifibranor data readout expected Q4 2026.
BNTXIVAbiopharmaceuticalPhase 3 trial
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Inventiva Bolsters Executive Team Ahead of Critical Lanifibranor Phase 3 Data

Inventiva appoints three new executives to strengthen leadership before anticipated Phase 3 lanifibranor trial results expected in Q4 2026.
IVAGeneral CounselPhase 3 trial
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Exponent Promotes Pye to President, Names Anderson CFO in Major Leadership Reshuffle

Exponent promotes John Pye to President and Eric Anderson to CFO, with Rich Schlenker transitioning to Executive VP and board candidacy under CEO Catherine Corrigan.
EXPOboard of directorsexecutive leadership
GlobeNewswire Inc.GlobeNewswire Inc.··Kalmar Corporation

Kalmar Corporation Executes Major Leadership Reshuffle as Finance Chief and Services Head Exit

Kalmar Corporation announces CFO transition and Services President departure after 36 years, with both executives aiding handover through year-end.
VLMTYorganizational restructuringChief Financial Officer
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Lyell Immunopharma Secures $50M Funding Tranche on Clinical Progress

Lyell Immunopharma closes $50M funding tranche, advances ronde-cel in pivotal lymphoma trial, appoints new CFO with extended cash runway through Q2 2027.
LYELCAR T-cell therapycash runway